These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12915335)
1. Meeting the challenge of treating epilepsy. Chadwick D; Wolf P Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335 [No Abstract] [Full Text] [Related]
2. Neuroprotection possibilities in epileptic children. Artemowicz B; Sobaniec W Rocz Akad Med Bialymst; 2005; 50 Suppl 1():91-5. PubMed ID: 16119636 [TBL] [Abstract][Full Text] [Related]
3. Issues in the treatment of epilepsy. Leppik IE Epilepsia; 2001; 42 Suppl 4():1-6. PubMed ID: 11564117 [No Abstract] [Full Text] [Related]
4. Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities. Deb S; Kaur Saini ST J Intellect Disabil Res; 2007 Jul; 51(Pt 7):564-5. PubMed ID: 17537170 [No Abstract] [Full Text] [Related]
5. [The value of levetiracetam in epileptic status]. Pastor-Milán E; González-Torres V; Vilches R Rev Neurol; 2005 Oct 16-31; 41(8):508-9. PubMed ID: 16224741 [No Abstract] [Full Text] [Related]
6. Role of levetiracetam in the treatment of epilepsy. Brodie MJ; French JA Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344 [TBL] [Abstract][Full Text] [Related]
9. Clinical development of levetiracetam for amyotrophic lateral sclerosis. Davies SL; Moral MA Drug News Perspect; 2006 Nov; 19(9):572-3. PubMed ID: 17220961 [TBL] [Abstract][Full Text] [Related]
10. [Keppra in epilepsy treatment: efficacy and tolerability]. Mukhin KIu; Pilin SV; Chadaev VA; Mironov MB; Petrukhin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):49-51. PubMed ID: 15704484 [No Abstract] [Full Text] [Related]
11. The SKATE study: interim analysis. Olwen GO Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896 [TBL] [Abstract][Full Text] [Related]
12. [Levetiracetam (keppra) in epileptology]. Kalinin VV Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):74-7. PubMed ID: 18683359 [No Abstract] [Full Text] [Related]
13. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. Krief P; Li Kan ; Maytal J J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575 [TBL] [Abstract][Full Text] [Related]
14. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy. Belcastro V; Costa C; Galletti F; Rossi A; Tambasco N; Striano P Epilepsy Behav; 2009 Jan; 14(1):269-70. PubMed ID: 18804185 [No Abstract] [Full Text] [Related]
15. Letter: Antiepileptogenic and neuroprotective effects of erythropoietin: recent data. Mikati MA; Mohler Cornett KM Epilepsia; 2009 Jun; 50(6):1654-5. PubMed ID: 19646143 [No Abstract] [Full Text] [Related]
16. Initial management of epilepsy. Ammar H; Malani A; Mughal S N Engl J Med; 2008 Dec; 359(23):2500; author reply 2500. PubMed ID: 19065751 [No Abstract] [Full Text] [Related]
17. Suicidal ideation in epilepsy and levetiracetam therapy. Mula M; Sander JW Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331 [TBL] [Abstract][Full Text] [Related]
18. Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model. Gibbs JE; Cock HR Epilepsy Res; 2007 Feb; 73(2):208-12. PubMed ID: 17085017 [TBL] [Abstract][Full Text] [Related]
19. [The renewing drug therapy of epilepsy]. Keränen T; Kälviäinen R Duodecim; 1997; 113(18):1749-54. PubMed ID: 10892066 [No Abstract] [Full Text] [Related]